InterCure Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was ILS 208.61 million compared to ILS 182.51 million a year ago. Net income was ILS 5.1 million compared to ILS 29.01 million a year ago.

Basic earnings per share from continuing operations was ILS 0.11 compared to ILS 0.64 a year ago. Diluted earnings per share from continuing operations was ILS 0.11 compared to ILS 0.64 a year ago.